ERS technical standard: Exhaled biomarkers in lung disease Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring Year: 2017
A European Respiratory Society technical standard: exhaled biomarkers in lung disease Source: Guideline 2017 Year: 2017
A European Respiratory Society technical standard: exhaled biomarkers in lung disease Source: Guideline 2017 Year: 2017
A European Respiratory Society technical standard: exhaled biomarkers in lung disease Source: Eur Respir J , 49 (4) 1600965; DOI: 10.1183/13993003.00965-2016 Year: 2017
Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010
Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015
Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019
Technical problems with measurements of biomarkers - exhaled breath condensate Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017
The recent multi-ethnic global lung initiative 2012 (GLI2012 ) reference values don’t reflect contemporary Mediterranean spirometry Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Asthma diagnosis based on either exhaled NO, lung function or methacholine challenge in symptomatic subjects Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012
Airway inflammation: exhaled NO measurement in clinical practice Source: ISSN=ISSN 1810-6838, ISBN=, page=228 Year: 2005